MILLENNIUM MANAGEMENT LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,990,000
-27.2%
585,406
-19.5%
0.00%
-50.0%
Q2 2018$2,734,000
-28.9%
727,124
-22.7%
0.00%
-20.0%
Q1 2018$3,847,000
-62.5%
940,589
-34.9%
0.01%
-68.8%
Q3 2017$10,257,000
-23.6%
1,444,625
-22.2%
0.02%
-33.3%
Q2 2017$13,418,000
+70.9%
1,855,839
+45.6%
0.02%
+71.4%
Q1 2017$7,850,000
+56.3%
1,274,420
+48.7%
0.01%
+27.3%
Q4 2016$5,023,000
+266.9%
857,234
+232.6%
0.01%
+450.0%
Q3 2016$1,369,000
-78.7%
257,730
-73.5%
0.00%
-86.7%
Q2 2016$6,427,000
+345.4%
970,804
+214.1%
0.02%
+275.0%
Q1 2016$1,443,000
-69.6%
309,047
-67.2%
0.00%
-60.0%
Q4 2015$4,754,000
+3320.1%
941,334
+2282.7%
0.01%
Q3 2015$139,000
-97.8%
39,507
-93.8%
0.00%
-100.0%
Q2 2015$6,402,000
+133.1%
641,448
+197.2%
0.01%
+140.0%
Q1 2015$2,747,000
+197.0%
215,802
+230.3%
0.01%
+150.0%
Q4 2014$925,000
+51.9%
65,341
+65.1%
0.00%0.0%
Q2 2014$609,000
+87.4%
39,565
+107.6%
0.00%
+100.0%
Q1 2014$325,000
-89.0%
19,056
-91.6%
0.00%
-88.9%
Q4 2013$2,948,000
-23.2%
227,670
-40.1%
0.01%
-25.0%
Q3 2013$3,838,000
-54.0%
380,363
-65.9%
0.01%
-53.8%
Q2 2013$8,337,0001,116,0140.03%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders